Study design
Fifty-two eligible participants were randomized and allocated into the control (only pharmacological treatment, Study design. We randomly divided participants into intervention and control groups at a 1:1 ratio. In addition, patients in the intervention group were randomly assigned to a 4 weeks internet-based or in-person intervention, with subsequent crossover to the other group for 4 weeks.